)
)
)
Shifting International Regulatory Exclusivity Frameworks and Their Impact on Dispute Strategy
Regulatory data protection (RDP) and market exclusivity frameworks are evolving rapidly across major pharmaceutical markets, both in Europe and internationally, with important implications for how companies plan for market entry and manage product lifecycles. Focusing on the EU Pharma Package and new RDP measures designed to strengthen exclusivity protection in China, this session explores how recent regulatory reforms will reshape litigation dynamics and global exclusivity strategies.
- Assess how exclusivity reforms under the EU Pharma Package will impact market entry strategies and life science dispute dynamics.
- Learn about new RDP measures in China and how they will interact with patent linkage and broader exclusivity frameworks.
- Review the latest international legislative developments relating to RDP, market exclusivity and patent term extensions.
- Discuss how companies should align lifecycle management and exclusivity strategies across international markets.
